Photocure ASA (OSL:PHO)
64.00
+0.40 (0.63%)
Aug 5, 2025, 12:44 PM CET
DISH Network Revenue
Photocure ASA had revenue of 135.60M NOK in the quarter ending June 30, 2025, a decrease of -6.77%. This brings the company's revenue in the last twelve months to 522.89M, up 1.81% year-over-year. In the year 2024, Photocure ASA had annual revenue of 525.39M with 4.94% growth.
Revenue (ttm)
522.89M
Revenue Growth
+1.81%
P/S Ratio
3.24
Revenue / Employee
5.23M
Employees
101
Market Cap
1.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 525.39M | 24.73M | 4.94% |
Dec 31, 2023 | 500.66M | 107.53M | 27.35% |
Dec 31, 2022 | 393.13M | 32.59M | 9.04% |
Dec 31, 2021 | 360.54M | 104.06M | 40.57% |
Dec 31, 2020 | 256.48M | -25.07M | -8.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 603.92M |
Nordhealth AS | 545.88M |
Vistin Pharma ASA | 440.66M |
Omda AS | 442.14M |
ArcticZymes Technologies ASA | 102.97M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |
Nykode Therapeutics AS | 87.09M |